← Evidence map

TrialAnnals of the rheumatic diseases2012

Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study.

Asta Baranauskaite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

74 papers cite itlatest 60 shown

2012
…
2014
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 21994233